Uniqure n.v.

Major-Pharmaceuticals

QURE


Paasheuvelweg 25a
Amsterdam , 1105 BP

Executive/
Director

Price

  • Last Close
  • $ 6.59
    $ +0.3 4.77 %
    Dec 5, 2024
  • 52-Week High/Low
  • $8.72 - $4.41
  • YTD
  • -2.7%

  • Trading Volume
  • 50,044
  • Market Cap Full
  • $ 315.1M
  • Shares Outstanding
  • 47.8M
    Nov 2, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 64.2% -28.2% 3.2% 20% 107% -5% -6.8% -13.6% -11.2% -23.2%
Q2 11% -38% 7.1% 71.8% 28% 4% -8.6% 3.3% -43.1% -4.4%
Q3 -24.3% 3.8% 55.1% -7.1% -48.4% 8% 3.9% 0.6% -41.5% -
Q4 -19.1% -26.8% 88.6% -15.1% 80.7% -2.1% -34.7% 20.8% 9.6% -
J F M A M J J A S O N D
2024 -17.9% 3.4% -9.6% -4.2% - - - - - - - -
2023 -6.3% -1.4% -3.9% -3.6% -0.6% -40.6% -9.5% -16% -23% -15.1% 19% -0.2%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%12%-66%250%47%149%-50%-42%9%-70%-3%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.75 0.92 0.80 -0.59 -0.74 -0.63 -0.91 -1 -1.63
Q2 0.96 0.98 0.83 -0.57 -0.83 -0.96 8.51 -0.84 -1.44
Q3 0.75 0.60 0.40 -0.59 -0.58 -1.21 -0.79 -1.02 -1.88
Q4 0.64 0.58 0.91 -0.59 -0.96 -0.01 0.23 0.15 -
A 3.1 3.1 2.9 -2.3 -3.1 -2.8 7 -2.7 -4.95

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar 31.8 37.6 44.3 45 46.5 47
Jun - 37.8 44.3 46 46.6 47.6
Sep 37.1 37.9 44.4 46.1 46.7 47.7
Dec 37.3 43.6 44.5 46.2 46.8 47.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.3 - - - -
Fixed Asset Turnover 1.1 10.5 1.1 0.2 0.4
Total Asset Turnover 0.2 0.7 0.1 - -
Leverage
Debt Ratio 0.2 0.2 0.1 0.1 0.2
Debt – Equity Ratio 0.2 0.2 0.2 0.1 0.2
Interest Coverage 8.9 -16.4 - -40.3 17.6
Equity multiplier 0.2 0.1 0.1 0.1 0.2